Rosemont expands its offering with portfolio acquisition from Lucis Pharma Ltd The acquisition brings accelerated growth opportunities through a broadened portfolio with access to new attractive product areas, as well as further pipeline products. Rosemont Pharmaceuticals (Rosemont) is pleased to announc.